Cytosorbents CorporationCTSONASDAQ

Revenue (LTM)

$36M

+14.5% YoY

Net Income (LTM)

$-21M

+29.2% YoY

Free Cash Flow

$-15M

Revenue CAGR (5Y)

-2.5%

Marginsdeclining

FCF($0.0B)

Unprofitable

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Revenue	39	40↑1.7%	35↓13.5%	31↓10.4%	36↑14.5%
Gross Profit	28	29↑2.3%	21↓28.7%	22↑5.9%	25↑14.5%
Operating Income	-10	-23↓119.3%	-32↓38.6%	-32↓1.4%	-17↑47.5%
Net Income	-8	-25↓213.4%	-33↓33.6%	-29↑10.9%	-21↑29.2%
EBITDA	-10	-22↓122.6%	-30↓38.8%	-28↑7.1%	-15↑45.4%
EPS Diluted	-0.20	-0.57↓185.0%	-0.75↓31.6%	-0.65↑13.3%	-0.38↑41.5%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Cash & Equivalents	71	52↓27.0%	22↓57.5%	14↓36.2%	3↓76.8%
Total Current Assets	82	64↓22.0%	34↓47.5%	26↓23.9%	22↓15.9%
Total Assets	90	90↓0.5%	63↓29.4%	53↓15.8%	47↓11.1%
Total Current Liabilities	10	14↑34.8%	10↓29.0%	15↑49.7%	10↓32.5%
Total Liabilities	11	27↑151.0%	28↑3.4%	30↑7.6%	36↑20.9%
Total Equity	79	63↓21.0%	35↓43.5%	23↓34.2%	11↓52.3%
Total Debt	1	14↑1243.0%	18↑32.0%	18↑0.3%	27↑46.9%
Net Debt	-70	-38↑45.6%	-4↑89.8%	4↑207.4%	24↑464.6%

Metric	Dec 20	Dec 21	Dec 22	Dec 23	Dec 24
Operating Cash Flow	-6	-14↓149.5%	-28↓101.6%	-22↑23.3%	-14↑33.4%
Capital Expenditure	-2	-4↓155.4%	-6↓50.8%	-1↑85.5%	-0↑69.6%
Free Cash Flow	-7	-18↓150.9%	-35↓89.7%	-23↑34.9%	-15↑34.9%
Stock-Based Comp	5	6↑31.8%	4↓38.7%	4↓2.6%	4↑1.6%
Net Change in Cash	59	-18↓129.7%	-30↓70.5%	-8↑72.6%	-6↑28.8%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance